chronic obstructive pulmonary disease Clinical Trials and Research
Also known as: copd, emphysema, chronic bronchitis, smoker's lung, chronic airflow obstruction, chronic obstructive lung disease · ICD-10: J44
Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that make breathing difficult. Clinical trial research focuses on developing new treatments to manage symptoms, prevent flare-ups, and improve quality of life. Find a Trial helps patients search for active studies.
Search chronic obstructive pulmonary disease trials →
Common questions about chronic obstructive pulmonary disease clinical trials
Who can participate in COPD clinical trials?
Eligibility criteria vary by study, often including age, disease severity, and overall health. Researchers use these criteria to ensure patient safety and collect relevant data, as found on ClinicalTrials.gov. It's important to review specific requirements for each trial.
What are the different phases of COPD clinical trials?
Clinical trials typically progress through phases 1, 2, and 3, testing safety, dosage, and effectiveness, respectively. Phase 4 studies occur after a treatment is approved, monitoring long-term effects. This structured approach helps ensure thorough evaluation, as detailed on ClinicalTrials.gov.
What are current research directions for COPD treatments?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores new bronchodilators, anti-inflammatory drugs, and therapies targeting specific disease pathways. Studies also investigate non-pharmacological interventions like pulmonary rehabilitation and novel oxygen delivery systems.
What types of interventions are tested in COPD trials?
Interventions in COPD trials include new medications, such as inhaled therapies or oral drugs, and non-drug approaches like oxygen therapy, pulmonary rehabilitation programs, or surgical techniques. These aim to improve lung function, reduce symptoms, and prevent exacerbations, with data available on ClinicalTrials.gov.
Are there specific biomarkers important in COPD clinical trials?
Researchers often study biomarkers like inflammatory markers (e.g., C-reactive protein), specific genetic variations, or imaging findings to understand disease progression and treatment response. This helps personalize therapies and identify patient subgroups, according to NIH RePORTER.
Do patients have to pay to participate in COPD clinical trials?
Generally, study-related medical care and interventions in clinical trials are provided at no cost to participants. However, some costs like travel or lost wages may not be covered. Details are outlined in the informed consent process, as per ClinicalTrials.gov guidelines.
What common factors might exclude someone from a COPD trial?
Common exclusion criteria might include other significant lung diseases, severe heart conditions, active cancer, or recent respiratory infections. These factors help ensure patient safety and study integrity, allowing researchers to focus on specific patient populations, as noted on ClinicalTrials.gov.
What are the potential benefits and risks of joining a COPD trial?
Potential benefits include access to new treatments and close medical monitoring. Risks can involve side effects, inconvenience, or that the treatment may not be effective. These are fully explained before participation, allowing individuals to make an informed decision, per ClinicalTrials.gov.
How to find a chronic obstructive pulmonary disease trial that fits you
- Describe your chronic obstructive pulmonary disease situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all chronic obstructive pulmonary disease trials →